CD160 Protein, Human (HEK293, His-Avi)

CD160 Protein, present on immune cells, functions as a receptor delivering stimulatory or inhibitory signals, intricately regulating cell activation and differentiation. Existing in GPI-anchored and transmembrane forms, it likely initiates distinct signaling pathways in NK cells and T cells. Acting as a receptor for classical and non-classical MHC class I molecules, it recognizes HLA-C, triggering NK cell cytotoxicity during viral infections. On CD8+ T cells, CD160 binds HLA-A2-B2M, providing costimulation but may inhibit TCR signaling in memory CD8+ T cells during chronic viral infections. Recognizing HLA-G on endothelial cells, CD160 controls angiogenesis. It also participates in bidirectional cell-cell contact signaling with TNFRSF14, modulating immune responses, including anti-tumor responses and bacterial infections. The soluble GPI-cleaved form released by activated lymphocytes might limit lymphocyte effector functions. CD160 Protein, Human (HEK293, His-Avi) is the recombinant human-derived CD160 protein, expressed by HEK293, with C-Avi, C-His labeled tag. The total length of CD160 Protein, Human (HEK293, His-Avi) is 134 a.a., with molecular weight of 27-33 kDa.

CD160 Protein, found on immune cells, serves as a receptor capable of delivering stimulatory or inhibitory signals that intricately regulate cell activation and differentiation. Existing in both GPI-anchored and transmembrane forms, each likely initiating distinct signaling pathways in activated NK cells via phosphoinositide 3-kinase and in activated T cells via LCK and CD247/CD3 zeta chain. It acts as a receptor for both classical and non-classical MHC class I molecules, recognizing HLA-C during acute viral infections and triggering NK cell cytotoxic activity, contributing to the anti-viral innate immune response. On CD8+ T cells, CD160 binds HLA-A2-B2M, providing a costimulatory signal to activated/memory T cells. However, during persistent antigen stimulation, as observed in chronic viral infections, it may progressively inhibit TCR signaling in memory CD8+ T cells, contributing to T cell exhaustion. On endothelial cells, CD160 recognizes HLA-G, controlling angiogenesis in immune privileged sites. It also acts as a receptor or ligand for TNFRSF14, participating in bidirectional cell-cell contact signaling between antigen-presenting cells and lymphocytes, modulating immune responses in various contexts, including anti-tumor responses and bacterial infections. The soluble GPI-cleaved form, typically released by activated lymphocytes, might play a role in immune regulation by limiting lymphocyte effector functions.

Human

HEK293

C-Avi;C-His

O95971 (G25-L158)

11126  [NCBI]

27-33 kDa

Greater than 95% as determined by Tris-Bis PAGE.

<1 EU/μg, determined by LAL method.